Penumbra Inc

Common Name

Penumbra

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

4,500

Ticker

PEN

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.penumbrainc.com

Description

Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the co... Show more

Income Statement Balance Sheet Group Entities

Penumbra's Financial Statements Preview

Below are the financial statements of Penumbra, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	324.4^a	167.49^a
Marketable investments	15.73^a	121.7^a
Accounts receivable, net	167.67^a	201.77^a
Inventories	406.74^a	388.02^a
Prepaid expenses and other current assets	36.59^a	36.42^a
Total current assets	951.13^a	915.4^a
Property and equipment, net	62.64^a	72.69^a
Operating lease right-of-use assets	177.79^a	188.76^a
Finance lease right-of-use assets	28.02^a	31.09^a
Intangible assets, net	6.51^a	71.06^a
Goodwill	165.83^a	166.27^a
Deferred taxes	100.33^a	85.16^a
Other non-current assets	40.94^a	25.88^a
Total assets	1,533.18^a	1,556.31^a
Liabilities and stockholders’ equity	—	—
Current liabilities	—	—
Accounts payable	31.33^a	27.16^a
Accrued liabilities	112.43^a	110.56^a
Current operating lease liabilities	12.22^a	11.2^a
Current finance lease liabilities	2.37^a	2.23^a
Total current liabilities	158.35^a	151.14^a
Non-current operating lease liabilities	187.07^a	197.23^a
Non-current finance lease liabilities	21.73^a	23.68^a
Other non-current liabilities	15.11^a	5.31^a
Total liabilities	382.25^a	377.36^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0.04^a	0.04^a
Additional paid-in capital	1,096.73^a	1,047.2^a
Accumulated other comprehensive loss	-5.84^a	-3.15^a
Retained earnings	60^a	134.86^a
Total stockholders’ equity	1,150.93^a	1,178.94^a
Total liabilities and stockholders’ equity	1,533.18^a	1,556.31^a

Download Data

Verified Sources Behind Penumbra’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Penumbra’s data sources below and access millions more through our Disclosure Search.

a. Penumbra's 10-K 2024

b. Penumbra's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Penumbra Inc

Penumbra's Financial Statements Preview

Verified Sources Behind Penumbra’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Transmedics Group Inc

Globus Medical Inc

Zimmer Biomet Holdings Inc

Bio Rad Laboratories Inc

Procept Biorobotics Corp

Masimo Corp